Use of health-related quality of life in prescribing research. Part 1: Why evaluate health-related quality of life?

Journal of Clinical Pharmacy and Therapeutics

Volumn 28, Issue 6, 2003, Pages 513-521

  Calvert, M J ^a   Freemantle, N ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Chronic disease; Clinical practice; Health policy; Health related quality of life; Licensing

Indexed keywords

ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; HUMAN; INSTRUMENTATION; LICENSING; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PATIENT ATTITUDE; PERCEPTION; QUALITY OF LIFE;

ADOLESCENT; ADULT; BIOMEDICAL TECHNOLOGY; CHRONIC DISEASE; HEALTH STATUS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0346962898     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0269-4727.2003.00521.x     Document Type: Article

References (56)

1. World Health Organization (2002) Active ageing a policy framework. Noncommunicable Disease Prevention and Health Promotion Department, 1-60.
2. Centers for Disease Control and Prevention (2003) Public health and aging: trends in aging - United States and worldwide. JAMA 289, 1371-1373.
3. Report of a Joint WHO/FAO Expert Consultation (2003) Diet nutrition and the prevention of chronic diseases. htrp://www.who.int/hpr/NPH/docs/who_fao_ expert_report.pdf (accessed 19/06/2003).
4. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N, for the European Regulatory Issues on Quality of Life Assessment Group (2002) Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209-238.
5. Introducing the WHOQOL instruments. http:// www.who.int/evidence/ assessment-instruments/ qol/ql1.htm (accessed 02/06/2003).
6. Fairclough DL (2002) Design and analysis of quality of life studies in clinical trials. Boca Raton: Chapman & Hall/CRC.
7. Rector TS, Tschumperlin LK, Kubo SH et al. (1995) Use of the Living With Heart Failure questionnaire to ascertain patients' perceptives on improvement in quality of life versus risk of drug-induced death. Journal of Cardiac Failure, 1, 201-206.
8. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW (2001) Preferences for quality of life or survival expressed by patients with heart failure. The Journal of Heart and Lung Transplantation, 20, 1016-1024.
9. Cohn JN, Goldstein SO, Greenberg BH et al. (1998) A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. New England Journal of Medicine, 339, 1810-1816.
10. Cowley AJ, Skene AM, on behalf of the Enoximone Investigators (1994) Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. British Heart Journal, 72, 226-230.
11. Higginson IJ, Carr AJ (2001) Measuring quality of life: using quality of life measures in the clinical setting. BMJ, 322, 1297-1300.
12. Brundage M, Leis A, Bezjak A et al. (2003) Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study. Quality of Life Research, 12, 395-404.
13. Gridelli C, Cortesi E, Roila F (2001) Survival and quality of life: comparing end points in oncology. Annals of Oncology 12, S1.
14. Fayers PM, Machin D (2000) Quality of life assessment, analysis and interpretation. Chichester: Wiley.
15. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL (1998) Stroke unit treatment improves long-term quality of life: a randomized controlled trial. Stroke, 29, 895-899.
16. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38, 1351-1357.
17. Alla F, Briancon S, Guillemin F et al. (2002) Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. European Journal of Heart Failure, 4, 337-343.
18. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ, 324, 1417.
19. Mapi Research Institute. http://www.qolid.org (accessed 19/06/2003).
20. Sanders C, Egger M, Donovan J, Tallon D, Frankel S (1998) Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ, 317, 1191-1194.
21. Kind P (2001) The measurement of quality of life in clinical trials: considerations of good research practice. Report of the ISPOR Health Science Committee. http://www.ispor.org/workpaper/healthscience/ TFQoL.pdf (accessed 15/10/2003).
22. http://www.sf-36.org (accessed 19/06/2003).
23. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The Sickness Impact Profile: development and final revision of a health status measure. Medical Care, 19, 787-805.
24. John Hopkins Arthritis (2003) Management arthritis and health-related quality of life. http://hopkins-arthritis.org/mngmnt/qol.html (accessed 30/05/2003).
25. Kaplan RM, Bush JW, Berry CC (1979) Health status index category rating versus magnitude estimation for measuring levels of well-being. Medical Care, 17, 501-525.
26. Brooks R, de Charro F (1996) EuroQol: the current state of play. Health Policy, 37, 53-72.
27. http://www.euroqol.org (accessed 19/06/2003).
28. Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment 2, 1-74.
29. Dolan P (1997) Modeling valuations for EuroQol health states. Medical Care, 35, 1095-1108.
30. Billingham LJ, Abrams KR (2002) Simultaneous analysis of quality of life and survival data. Statistical Methods in Medical Research, 11, 25-48.
31. Velikova G, Stark D, Selby P (1999) Quality of life instruments in oncology. European Journal of Cancer, 35, 1571-1580.
32. Aaronson NK, Ahmedzai S, Bergman B et al. (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.
33. Rector TS, Kubo SH, Cohn JN (1987) Patients' self-assessment of their cogestive heart failure, Part 2: Content, reliability and validity of a new measure, the Minnesota living with Heart Failure Questionnaire. Heart Failure, Oct/Nov, 198-209.
34. Meenan RF, Gertman PM, Mason JH, Dunaif R (1982) The Arthritis Impact Measurement Scales: further investigations of a health status measure. Arthritis and Rheumatism, 25, 1048-1053.
35. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis and Rheumatism, 35, 1-10.
36. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
37. Beck AT, Steer RA (1984) Internal consistencies of the original and revised Beck Depression Inventory. Journal of Clinical Psychology, 40, 1365-1367.
38. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.
39. Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain, 1, 277-299.
40. Eisen GM, Locke GR, Provenzale D (1999) Health-related quality of life: a primer for gastroenterologists. American Journal of Castroenterology, 94, 2017-2021.
41. Calvert MJ, Freemantle N (2004) Research note: Use of health-related quality of life in prescribing research, Part 2. Journal of Clinical Pharmacy and Therapeutics, In press.
42. Altman D (1993) Practical statistics for medical research. London: Chapman and Hall.
43. Crosby RD, Kolotkin RL, Williams GR (2003) Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56, 395-407.
44. Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407-415.
45. Straus SE, Sackett DL (1998) Getting research findings into practice: using research findings in clinical practice. BMJ, 317, 339-342.
46. Edwards A, Elwyn G, Mulley A (2002) Explaining risks: turning numerical data into meaningful pictures. BMJ, 324, 827-830.
47. Bezjak A, Ng P, Skeel R, DePetrillo AD, Comis R, Taylor KM (2001) Oncologists' use of quality of life information: results of a survey of Eastern Cooperative Oncology Group physicians. Quality of Life Research, 10, 1-13.
48. Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK (2002) Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA, 288, 3027-3034.
49. Morris J, Perez D, McNoe B (1998) The use of quality of life data in clinical practice. Quality of Life Research, 7, 85-91.
50. Apolone G, De Carli G, Brunetti M, Garattini S (2001) Health-related quality of life (HR-QOL) and regulatory issues. Pharmacoeconomics, 19, 187-195.
51. Mapi Research Institute. http://www.mapi-research-inst.com/eriqa01.asp (accessed 19/06/ 2003).
52. National Institute for Clinical Excellence (2001) Guidance for manufacturers and sponsors. http:// www.nice.org.uk, pp.1-30. (accessed 04/07/2003).
53. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E (1999) Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months follow up. BMJ, 318, 833-837.
54. Badia X, Herdman M (2001) The importance of health-related quality-of-life data in determining the value of drug therapy. Clinical Therapeutics, 23, 168-175.
55. Barrett B, Locken K, Maberry R et al. (2002) The Wisconsin Upper Respiratory Symptom Survey (WURSS): new research instrument for assessing the common cold. Journal of Family Practice, 51, 265.
56. Lee CW, Chi KN (2000) The standard of reporting of health-related quality of life in clinical cancer trials. Journal of Clinical Epidemiology, 53, 451-458.